OneMedNet earnings release, November 9, 2026

ONMD · 2026-11-09 08:30 BMO ET · 8-K on SEC

Headline numbers

not stated in the 8-K

Revenue breakdown

not stated in the 8-K

Margins and costs

  • Gross margin not stated in the 8-K
  • Operating expenses not stated in the 8-K
  • One-offs in the quarter not stated in the 8-K
  • Effective tax rate not stated in the 8-K
  • Non-GAAP bridge not stated in the 8-K

KPIs

not stated in the 8-K

Guidance

not stated in the 8-K

What drove it

  • Revenue story not stated in the 8-K
  • EPS story not stated in the 8-K
  • One-off check not stated in the 8-K

The good

  • none

The bad

  • none

The ugly

  • none

Open questions

  • none
Full release

OneMedNet (ONMD) earnings release, November 9, 2026

OneMedNet Corp (ONMD) · Form 8-K, Item 2.02 · Filed · SEC filing

Exhibit

99.1

OneMedNet

Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap

Contracted

Demand Now Stands at Nearly 14 Times Full-Year 2025 Bookings, with Roughly Half of 2026 Contracts from New Customers

Source:

OneMedNet

Corporation

MINNEAPOLIS,

Nov. 09, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,” “we,”

“us” or “our”), a leading provider of First-Party (Direct-from-Source) regulatory decision-grade, AI-driven Real-World

Data (RWD), today announced that bookings reached approximately

$18.76 million year-to-date as of November 6, 2026, of which $1.388 million has been converted to revenue through September 30, 2026.

The announcement accompanies the release of “OneMedNet by the Numbers,” a growth recap summarizing the Company’s commercial and operational trajectory, drawn from the Company’s November 6, 2026 financial outlook, prior public disclosures, and SEC filings.

The full infographic is available at https://www.onemednet.com/investors#by-the-numbers.

“Our strategy is working,” said Aaron Green, President & CEO of OneMedNet. “We have focused on building strong relationships with industry leaders that already hold contracts across pharma and foundational AI, streamlining the contracting process and reducing our time to booking. Our platform allows us to deliver multi-modal data at the scale these customers require. The numbers in this recap are the result of our execution.”

About

OneMedNet Corporation

OneMedNet

Corporation is revolutionizing Real-World Data (RWD) through its iRWD™ platform, delivering regulatory decision-grade, AI-ready datasets that include de-identified medical imaging alongside comprehensive clinical records. With a network spanning more than 2,300 sites and encompassing over 90 million patient journeys and 270 million studies, OneMedNet serves life sciences companies, medical device manufacturers, AI developers, and other innovators seeking high-quality, compliant healthcare data. The Company’s platform supports applications ranging from drug development and regulatory submissions to foundational AI model training.

Learn more at www.onemednet.com.

Forward-Looking

Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section

21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements. These statements include, but are not limited to, statements regarding our preliminary results for the third quarter of 2026, our revenue outlook for the fourth quarter of 2026, our ability to convert bookings into recognized revenue, the timing of revenue recognition, and statements generally about our products, plans and strategies. Bookings are an operational metric, and there can be no assurance that bookings will convert into recognized revenue in the amounts or on the timeline anticipated.

Forward-looking statements are based on information available at the time those statements are made and were based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond our control. These risks and uncertainties include but are not limited to our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; the timing of customer acceptance and data delivery; and the other risks described in our most recent Annual

Report on Form 10-K and our subsequent filings with the Securities and Exchange Commission. Except as required by law, we do not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

OneMedNet

Contacts:

Michael

Wong, VP Marketing

Email: michael.wong@onemednet.com

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · OneMedNet earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.